| Danielle Elise Durie, MD | |
|
3900 Hamilton Blvd, Suite 201, Allentown, PA 18103-6122 | |
| (484) 664-7555 | |
| (484) 664-7550 |
| Full Name | Danielle Elise Durie |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 3900 Hamilton Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104952134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | MD442054 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Entity Name | Hazleton Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952464638 PECOS PAC ID: 8022110402 Enrollment ID: O20070305000195 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Entity Name | Valley Health Partners Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770118648 PECOS PAC ID: 4284065327 Enrollment ID: O20200505003199 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Elise Durie, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Danielle Elise Durie, MD 3900 Hamilton Blvd, Suite 201, Allentown, PA 18103-6122 Ph: (484) 664-7555 |
News Archive
"In an exciting move for the water, sanitation and hygiene (WASH) community, the U.S. Senate Foreign Relations Committee passed the Senator Paul Simon Water for the World Act of 2011 (S 641), bringing the bill one step closer to becoming a law," PSI's "Healthy Lives" blog reports.
The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.
A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 1 days ago
Dr. Rachel O'connell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 Cetronia Rd Ste 120, Allentown, PA 18104 Phone: 845-262-5204 | |
Treasure Ngozi Ada Walker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1245 S Cedar Crest Blvd Ste 201, Allentown, PA 18103 Phone: 610-402-4870 Fax: 610-402-4960 | |
Dr. Timothy M Pellini, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1245 S Cedar Crest Blvd, Suite 201, Allentown, PA 18103 Phone: 610-437-1931 Fax: 610-433-8791 | |
Shirin Azadi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1627 Chew St, Allentown, PA 18102 Phone: 610-402-6000 | |
Dr. Salam Syed, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Jennifer Melanie Heibig, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5100 | |
Dahlia Kronfli, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1628 Chew St, Allentown, PA 18102 Phone: 610-402-1600 |